News

The experimental drug is similar to the Boston-based company’s recently approved pill Journavx but could potentially be given ...
Early detection and management of lifestyle diseases at the 360 Degree Metabolic Centre in Alappuzha General Hospital.
Peripheral neuropathy affects millions, often leaving people feeling frustrated, dismissed, and stuck with symptoms like ...
Dr. Evan Norum, DC, BCN, founder of Advantage Neuropathy, joins us on The Morning Blend to discuss treatments for neuropathy.
A study led by doctors at the Medical University of South Carolina and UMass Chan Medical School found that ultrasound-guided ...
Unlike the brain and spinal cord, peripheral nerve cells, whose long extensions reach the skin and internal organs, are capable of regenerating after injury. This is why injuries to the central ...
TUESDAY, July 22, 2025 (HealthDay News) -- Peripheral neuropathy (PN) risk factors seem to explain a higher prevalence of the disease among non-Hispanic Black individuals, but not among Hispanic ...
A comprehensive review by researchers at Teerthanker Mahaveer University highlights critical molecular pathways—including PKC activation, oxidative stress, and inflammatory cytokines—driving diabetic ...
Bioventus (Nasdaq:BVS) announced today that it received FDA 510(k) clearance for both its TalisMann and StimTrial offerings.
Treatment with HCCP led to significant improvements in pain, sleep quality, mood, and overall quality of life in patients with PNI.
Peripheral neuropathy is nerve damage that causes burning, tingling, pain and numbness in the feet and hands. It can be debilitating and may eventually lead to falls, infection and even amputation.
A study published in July 2025 issue of BMC Neurology reported limited data on therapeutic plasma exchange (PE) and immunoadsorption (IA) in chronic inflammatory demyelinating polyneuropathy (CIDP), ...